Skip to main content

Guideline: The USPSTF recommends low- to moderate-dose statins to prevent CVD in selected adults 40 to 75 years of age.

Publication ,  Journal Article
Pagidipati, NJ; Granger, CB
Published in: Ann Intern Med
March 21, 2017

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Ann Intern Med

DOI

EISSN

1539-3704

Publication Date

March 21, 2017

Volume

166

Issue

6

Start / End Page

JC26

Location

United States

Related Subject Headings

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Humans
  • General & Internal Medicine
  • Cardiovascular Diseases
  • Adult
  • 3202 Clinical sciences
  • 11 Medical and Health Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Pagidipati, N. J., & Granger, C. B. (2017). Guideline: The USPSTF recommends low- to moderate-dose statins to prevent CVD in selected adults 40 to 75 years of age. Ann Intern Med, 166(6), JC26. https://doi.org/10.7326/ACPJC-2017-166-6-026
Pagidipati, Neha J., and Christopher B. Granger. “Guideline: The USPSTF recommends low- to moderate-dose statins to prevent CVD in selected adults 40 to 75 years of age.Ann Intern Med 166, no. 6 (March 21, 2017): JC26. https://doi.org/10.7326/ACPJC-2017-166-6-026.
Pagidipati, Neha J., and Christopher B. Granger. “Guideline: The USPSTF recommends low- to moderate-dose statins to prevent CVD in selected adults 40 to 75 years of age.Ann Intern Med, vol. 166, no. 6, Mar. 2017, p. JC26. Pubmed, doi:10.7326/ACPJC-2017-166-6-026.

Published In

Ann Intern Med

DOI

EISSN

1539-3704

Publication Date

March 21, 2017

Volume

166

Issue

6

Start / End Page

JC26

Location

United States

Related Subject Headings

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Humans
  • General & Internal Medicine
  • Cardiovascular Diseases
  • Adult
  • 3202 Clinical sciences
  • 11 Medical and Health Sciences